"the drug must be administered at the right time point during development," he said.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
.the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� .